Abstract
British Journal of Clinical PharmacologyVolume 16, Issue 4 p. 460-461 Free Access Sulphaphenazole and drug oxidation in man. DB Back, DB BackSearch for more papers by this authorBK Park, BK ParkSearch for more papers by this authorJF Tjia, JF TjiaSearch for more papers by this authorSN Newby, SN NewbySearch for more papers by this author DB Back, DB BackSearch for more papers by this authorBK Park, BK ParkSearch for more papers by this authorJF Tjia, JF TjiaSearch for more papers by this authorSN Newby, SN NewbySearch for more papers by this author First published: October 1983 https://doi.org/10.1111/j.1365-2125.1983.tb02199.xCitations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References CHRISTENSEN, L.K., HANSEN, J.M. & KRISTENSEN, M. (1963). Sulphaphenazole induced hypoglycaemic attacks in tolbutamide treated diabetics. Lancet, ii, 1298– 1301. DANHOF, M., DEGROOT-VAN DER VIS, E. & BREIMER, D.D. (1979). Assay of antipyrine and its primary metabolites in plasma, saliva and urine by HPLC and some preliminary results in man. Pharmacology, 18, 210– 223. EICHELBAUM, M., BERTILSSON, L., SAWE, J. & ZEKRON, C. (1982). Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities. Clin. Pharmac. Ther., 31, 184– 186. IDLE, J.R., SLOAN, T.P., SMITH, R.L. & WAKILE, L.A. (1979). Application of the phenotyped panel approach to the detection of polymorphisms of drug oxidation in man. Br. J. Pharmac., 66, 430– 431P. PARK, B.K. (1978). A direct radioimmunoassay for 6β-hydroxycortisol in human urine. J. steroid Biochem., 9, 963– 966. POND, S.M., BIRKETT, D.J. & WADE, D.N. (1977). Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulphaphenazole. Clin. Pharmac. Ther., 22, 573– 579. ROWLAND, M. & MATIN, S.B. (1973). Kinetics of drug-drug interactions. J. Pharmacokin. Biopharm., 1, 553– 567. SCHULZ, E. & SCHMIDT, F.H. (1970). Abbauhemmung von Tolbutamid durch Sulfaphenazol beim Menschen. Pharmac. Clin., 2, 150– 154. SCOTT, J. & POFFENBARGER, P.L. (1979). Pharmacogenetics of tolbutamide metabolism in humans. Diabetes, 28, 41– 51. Citing Literature Volume16, Issue4October 1983Pages 460-461 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
